The effect of resveratrol on reducing cholesterol in people with HIV. Human immunodeficiency virus [HIV] disease
Conditions
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Sustainable treatment with triple-drug regimen for at least 12 months. LDL> 130 mg / dL or triglyceride 200-500 mg / dL and HDL> 160 mg / dL, with no regular diet and exercise for at least 3 months
Exclusion criteria
Exclusion criteria: Exclusion criteria were: history of pre-antiretroviral lipid disorders, history of cardiovascular and / or cerebral disease, Cushing's syndrome, hypothyroidism, type 1 or type 2 diabetes, renal failure, previous or current treatment with reduced risk factors. Lipid donors, antihypertensive drugs or estrogens, current drug and / or alcohol abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Triglyceride. Timepoint: 1 month. Method of measurement: Each patient received 15 ml fasting venous blood before and after 1 month of treatment with resveratrol and placebo and sent to the laboratory.;Cholesterol. Timepoint: 1MONTH. Method of measurement: Each patient received 15 ml fasting venous blood before and after 1 month of treatment with resveratrol and placebo and sent to the laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Somayeh Karami Mohajeri
Kerman University of Medical Sciences
Outcome results
None listed